Correlation Between Bio Path and Elicio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bio Path and Elicio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Path and Elicio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Path Holdings and Elicio Therapeutics, you can compare the effects of market volatilities on Bio Path and Elicio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Path with a short position of Elicio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Path and Elicio Therapeutics.
Diversification Opportunities for Bio Path and Elicio Therapeutics
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Bio and Elicio is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and Elicio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elicio Therapeutics and Bio Path is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Path Holdings are associated (or correlated) with Elicio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elicio Therapeutics has no effect on the direction of Bio Path i.e., Bio Path and Elicio Therapeutics go up and down completely randomly.
Pair Corralation between Bio Path and Elicio Therapeutics
Given the investment horizon of 90 days Bio Path Holdings is expected to under-perform the Elicio Therapeutics. In addition to that, Bio Path is 1.06 times more volatile than Elicio Therapeutics. It trades about -0.1 of its total potential returns per unit of risk. Elicio Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest 615.00 in Elicio Therapeutics on August 26, 2024 and sell it today you would lose (122.00) from holding Elicio Therapeutics or give up 19.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bio Path Holdings vs. Elicio Therapeutics
Performance |
| Timeline |
| Bio Path Holdings |
| Elicio Therapeutics |
Bio Path and Elicio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bio Path and Elicio Therapeutics
The main advantage of trading using opposite Bio Path and Elicio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Path position performs unexpectedly, Elicio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elicio Therapeutics will offset losses from the drop in Elicio Therapeutics' long position.| Bio Path vs. Eliem Therapeutics | Bio Path vs. HCW Biologics | Bio Path vs. Scpharmaceuticals | Bio Path vs. Milestone Pharmaceuticals |
| Elicio Therapeutics vs. Capricor Therapeutics | Elicio Therapeutics vs. Soleno Therapeutics | Elicio Therapeutics vs. Bio Path Holdings | Elicio Therapeutics vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |